PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada; Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: maryamsharifian25@gmail.com.\', \'MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.\', \'Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.\', \'Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada; Department of Diagnostic Radiology, McGill University, Montreal, Quebec, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2211-0348(21)00066-310.1016/j.msard.2021.102800
?:doi
?:hasPublicationType
?:journal
  • Multiple sclerosis and related disorders
is ?:pmid of
?:pmid
?:pmid
  • 33578206
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.123
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: A systematic review.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all